Kidney disease — all decisions

The veteran withdrew his appeals for service connection for kidney disease and an earlier effective date for a retroactive increased evaluation to 70 percent for PTSD.

The Board denied service connection for kidney cancer and lung cancer, as the evidence did not support a causal or etiological relationship to any in-service disease, injury, incident, or exposure.

The Board remands the claims for service connection for chronic kidney disease, CML, hypertension, non-allergic rhinitis, and hypothyroidism to obtain a VA examination that addresses the Veteran's competent and credible statements of exposure to fumes as causing his conditions.

The Board granted service connection for kidney cancer, finding that the Veteran's exposure to Agent Orange during his service in Korea is likely responsible for the development of his condition.

The Board remands the issue of entitlement to service connection for chronic kidney disease, stage 4, due to a pre-decisional duty-to-assist error regarding the adequacy of the medical examination and opinion.

The Board denied the veteran's claim for service connection for kidney cancer, finding no evidence of a nexus between the condition and his military service, including exposure to herbicide agents.

The Board remands the claims for service connection for a skin cancer disability and kidney disability due to new and relevant evidence being submitted, necessitating further review.

The Board denied service connection for sleep apnea, left and right knee replacements, depression, anxiety, as there was no evidence of a current disability during the period on appeal. The claims for breast cancer and kidney cancer were remanded for further development.

The Board granted an earlier effective date of December 20, 2021, for the award of service connection for kidney cancer with nephrectomy based on direct service connection.

The appeals for service connection for posttraumatic stress disorder (PTSD), left kidney cancer and residuals, and prostate cancer and residuals are dismissed as there remains no question of law or fact for the Board to resolve.

The Board remands the claims for service connection for neurocognitive disorder, kidney disability, and special monthly compensation based on aid and attendance/housebound to obtain additional evidence.

The Board remands the claims for service connection due to exposure to contaminated water at Camp Lejeune, as further development is necessary.

The Board granted service connection for a parathyroid disability, kidney disability, and psychiatric disorder based on evidence of in-service toxic exposure risk activity (TERA).

The Board remands the claims for service connection for various conditions due to a need for VA examinations to explore their etiologies, particularly in relation to potential toxic exposures during service.

The Veteran's claim for a higher level of special monthly compensation for chronic kidney disease (CKD) at the intermediary level N1/2 is granted.

The Board denied the Veteran's claims for a compensable rating for eczema and bilateral hearing loss disability, and remanded the claims for service connection for kidney complex cysts, right wrist disability, and trigeminal neuralgia.

The Board granted service connection for diabetes, hypertension, and a heart condition due to presumed exposure to herbicide agents during military service in Korea. The claim for a kidney condition was remanded for further evidence.

The Board denied service connection for hypertension, coronary artery disease, congestive heart failure, carotid artery disease blockage with surgery, peripheral arterial disease, prostate cancer, bladder cancer, kidney cancer, and anxiety and depression as not being related to the Veteran's active duty or any herbicide exposure.

The Board denied service connection for cerebellar ataxia, kidney stones, and gastroesophageal reflux disease (GERD) as the Veteran's claimed conditions were not incurred during his active service.

The Board granted service connection for nephrolithiasis and kidney disease, stage IV based on a continuity of symptomatology after service.